The MCT1 gene expression analysis obtained from the GSE108474 dataset showed that there were significant differences when the expression levels obtained from brain biopsies of GBM patients were compared to other brain tumor stages (Figure 7). The gene discussed is SLC16A1; the disease is brain neoplasm.